Modeling the Dynamics of Heterogeneity of Solid Tumors in Response to Chemotherapy
暂无分享,去创建一个
[1] M. Gottesman,et al. Multidrug resistance in cancer: role of ATP–dependent transporters , 2002, Nature Reviews Cancer.
[2] J. Goldie,et al. A model for the resistance of tumor cells to cancer chemotherapeutic agents , 1983 .
[3] Mikko Niemi,et al. Genetics is a major determinant of expression of the human hepatic uptake transporter OATP1B1, but not of OATP1B3 and OATP2B1 , 2013, Genome Medicine.
[4] M. Nowak,et al. Evolution of resistance to cancer therapy. , 2006, Current pharmaceutical design.
[5] F. Michor,et al. Evolution of acquired resistance to anti-cancer therapy. , 2014, Journal of theoretical biology.
[6] Martin A Nowak,et al. Evolution of Resistance During Clonal Expansion , 2006, Genetics.
[7] J. Hinchion,et al. Releasing pressure in tumors: what do we know so far and where do we go from here? A review. , 2014, Cancer research.
[8] C. Swanton,et al. Intra-tumor heterogeneity: lessons from microbial evolution and clinical implications , 2013, Genome Medicine.
[9] Guillaume Lambert,et al. Cell motility and drug gradients in the emergence of resistance to chemotherapy , 2013, Proceedings of the National Academy of Sciences.
[10] B. Perthame,et al. Modeling the Effects of Space Structure and Combination Therapies on Phenotypic Heterogeneity and Drug Resistance in Solid Tumors , 2014, Bulletin of Mathematical Biology.
[11] L. Norton,et al. The Norton–Simon hypothesis: designing more effective and less toxic chemotherapeutic regimens , 2006, Nature Clinical Practice Oncology.
[12] A. Radunskaya,et al. Mathematical Model of Colorectal Cancer with Monoclonal Antibody Treatments , 2013, 1312.3023.
[13] D. Levy,et al. An elementary approach to modeling drug resistance in cancer. , 2010, Mathematical biosciences and engineering : MBE.
[14] Urszula Ledzewicz,et al. Optimal Control for Mathematical Models of Cancer Therapies: An Application of Geometric Methods , 2015 .
[15] Doron Levy,et al. The dynamics of drug resistance: a mathematical perspective. , 2012, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[16] G. Mickisch. Multidrug Resistance , 1996, Der Urologe A.
[17] Michael Travisano,et al. Adaptive radiation in a heterogeneous environment , 1998, Nature.
[18] Goldie Jh,et al. A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. , 1979 .
[19] P. Jabin,et al. Selection-Mutation dynamics with spatial dependence , 2016, 1601.04553.
[20] L. Liotta,et al. Mechanism of Cell Adaptation: When and How Do Cancer Cells Develop Chemoresistance? , 2011, Cancer journal.
[21] N. Komarova,et al. Stochastic modeling of drug resistance in cancer. , 2006, Journal of theoretical biology.
[22] J H Goldie,et al. A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. , 1979, Cancer treatment reports.
[23] Leilei Peng,et al. Holographic optical coherence imaging of rat osteogenic sarcoma tumor spheroids. , 2004, Applied optics.
[24] S. Bates,et al. Reduced growth rate accompanied by aberrant epidermal growth factor signaling in drug resistant human breast cancer cells. , 2000, Biochimica et biophysica acta.
[25] Jan Paul Medema,et al. Cancer stem cells: The challenges ahead , 2013, Nature Cell Biology.
[26] E. Brodie,et al. CORRELATIONAL SELECTION FOR COLOR PATTERN AND ANTIPREDATOR BEHAVIOR IN THE GARTER SNAKE THAMNOPHIS ORDINOIDES , 1992, Evolution; international journal of organic evolution.
[27] S. Jonathan Chapman,et al. Mathematical Models of Avascular Tumor Growth , 2007, SIAM Rev..
[28] Alissa M. Weaver,et al. Tumor Morphology and Phenotypic Evolution Driven by Selective Pressure from the Microenvironment , 2006, Cell.
[29] M. Chaplain,et al. Continuous and Discrete Mathematical Models of Tumor‐Induced Angiogenesis , 1999 .
[30] M. Roizen,et al. Hallmarks of Cancer: The Next Generation , 2012 .
[31] Jean-Pierre Gillet,et al. Mechanisms of multidrug resistance in cancer. , 2010, Methods in molecular biology.
[32] Shannon M. Mumenthaler,et al. A high-content image-based method for quantitatively studying context-dependent cell population dynamics , 2016, Scientific Reports.
[33] B. Perthame,et al. Populational adaptive evolution, chemotherapeutic resistance and multiple anti-cancer therapies , 2012, 1207.0923.
[34] Goldie Jh,et al. Quantitative model for multiple levels of drug resistance in clinical tumors. , 1983 .
[35] Sean C. Bendall,et al. viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia , 2013, Nature Biotechnology.
[36] I. Tannock,et al. Drug penetration in solid tumours , 2006, Nature Reviews Cancer.
[37] L. D. Pillis,et al. A Validated Mathematical Model of Cell-Mediated Immune Response to Tumor Growth , 2005 .
[38] M. Gottesman. Mechanisms of cancer drug resistance. , 2002, Annual review of medicine.
[39] J. Panetta,et al. A mathematical model of drug resistance: heterogeneous tumors. , 1998, Mathematical biosciences.
[40] P. Okunieff,et al. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. , 1989, Cancer research.
[41] M. Gottesman,et al. The Role of Cell Density and Intratumoral Heterogeneity in Multidrug Resistance , 2013 .
[42] B. Perthame,et al. Asymptotic analysis of a selection model with space , 2014, 1407.5870.
[43] S Gallivan,et al. A mathematical model of the development of drug resistance to cancer chemotherapy. , 1987, European journal of cancer & clinical oncology.
[44] I. Tannock,et al. Drug resistance and the solid tumor microenvironment. , 2007, Journal of the National Cancer Institute.
[45] O. Jensen,et al. On a biophysical and mathematical model of Pgp-mediated multidrug resistance: understanding the “space–time” dimension of MDR , 2009, European Biophysics Journal.
[46] A. Grothey. Defining the role of panitumumab in colorectal cancer , 2006 .
[47] R. Arceci. Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing , 2012 .
[48] F. Schabel,et al. Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure. , 1975, Cancer research.
[49] William Pao,et al. The Impact of Microenvironmental Heterogeneity on the Evolution of Drug Resistance in Cancer Cells , 2015, Cancer informatics.
[50] M. Gottesman,et al. The Impact of Cell Density and Mutations in a Model of Multidrug Resistance in Solid Tumors , 2014, Bulletin of Mathematical Biology.
[51] Beverly A. Teicher,et al. Cancer Drug Resistance , 2006 .
[52] A. Świerniak,et al. Mathematical modeling as a tool for planning anticancer therapy. , 2009, European journal of pharmacology.
[53] Doron Levy,et al. Simplifying the complexity of resistance heterogeneity in metastasis. , 2014, Trends in molecular medicine.